Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea
· Delayed Price · Currency is KRW 88,500
-9,500 (-9.69%)
At close: Dec 5, 2025
Next Biomedical Revenue
Next Biomedical had revenue of 4.93B KRW in the quarter ending September 30, 2025, with 125.07% growth. This brings the company's revenue in the last twelve months to 14.90B, up 70.64% year-over-year. In the year 2024, Next Biomedical had annual revenue of 9.54B with 95.46% growth.
Revenue (ttm)
14.90B
Revenue Growth
+70.64%
P/S Ratio
48.71
Revenue / Employee
n/a
Employees
n/a
Market Cap
726.04B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| HD Hyundai Heavy Industries | 16.39T |
| KB Financial Group | 14.89T |